A number of recent trials have explored potential strategies for using immunotherapy in chronic lymphocytic leukemia (CLL).

Leukemia is classified as either chronic or acute, depending on how quickly it’s expected to develop. Chronic lymphocytic leukemia (CLL) is a slow-growing type of leukemia that develops in a ...

New research reveals 5 ways exercise enhances cancer treatment effectiveness, offering hope to patients with chronic ...

Targeted drugs, surgery, and radiation are common treatments for chronic lymphocytic leukemia (CLL), but complementary therapy can also play a role in helping manage your disease. Yoga can ...

In just over a year since its US Food and Drug Administration (FDA) approval, pirtobrutinib (Jayprica) has become a standard ...

Minimal residual disease negativity was achieved at a significantly higher rate with venetoclax-based therapies, supporting its role in CLL.

As a way to grieve, Meaghan started writing, those thoughts and feelings turned into a book called ‘Widows Can Love Again’.

NX-5948 assigned the nonproprietary name “bexobrutideg”U.S. FDA Orphan Drug Designation granted to bexobrutideg for the treatment of Waldenström ...

During a live event, Catherine J. Lee, MD, MS, discussed the mechanism of action of approved therapies for chronic ...

Reports Q1 revenue $18.45M, consensus $13.03M. “Nurix had a strong first quarter marked by important collaboration and regulatory achievements ...